Alexandros Polydorides
Anatomic Pathology · New York, NYNPI 1063617751
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,900 of the $35,354 with a category attached, or 67.6%. Agilent Technologies, Inc. accounts for 69.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $18,579 and has fallen 92.9% since, to $1,325 in 2025. Among anatomic pathology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $2946.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agilent Technologies, Inc.$25K
- Jazz Pharmaceuticals Inc.$7K
- Boehringer Ingelheim$3K
- E.r. Squibb & Sons, L.L.C.$1K
What the payments were for
- Consulting fees$10,77530%
- Speaking & faculty fees$23,90068%
- Travel & lodging$6792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agilent Technologies, Inc. | 9 | $24,579 |
| Jazz Pharmaceuticals Inc. | 1 | $6,750 |
| Boehringer Ingelheim | 1 | $2,700 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,325 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZANIDATAMAB$6,750
- PD-L1 IHC 28-8 pharmDx$6,000
How this compares
$35,354 in reported general payments places this provider in the 90th percentile of 152 anatomic pathology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in New York
- Jeremy SegalNew York$89K
- Richard AxelNew York$79K
- Marc LadanyiNew York$68K
- Laura TangNew York$48K
- Baljit SinghNew York$46K
- Oscar LinNew York$44K
- Neil TheiseNew York$31K
- Maureen ZakowskiNew York$26K
- Andre MoreiraNew York$25K
- Dara RossNew York$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.